hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Drug Saf
Autors principals: Hancox, Jules C., Melgari, Dario, Dempsey, Christopher E., Brack, Kieran E., Mitcheson, John, Ng, G. André
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2015
Matèries:
Letter to the Editor
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4530352/
https://ncbi.nlm.nih.gov/pubmed/26301071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098615595546
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars